Hey there,
Something bizarre is happening in biotech right now.
While revolutionary gene therapies are getting FDA approval and breakthrough treatments are reaching market, 16% of biotech companies are trading below their actual cash reserves. Access full story here.
-Christopher
P.S. Institutional investors are quietly buying at these levels for a specific reason. You really need to read this before it's too late.